NLS 1
Alternative Names: Epigallocatechin gallate octaacetate; Epigallocatechin-3-gallate derivative - Aptorum group; NLS-1 - Aptorum group; NLS1Latest Information Update: 05 Jun 2023
At a glance
- Originator H. Lee Moffitt Cancer Center and Research Institute; McGill University; PolyU Technology and Consultancy Company Limited; The Chinese University of Hong Kong; Wayne State University
- Class Catechins; Chemopreventatives; Flavonoids; Herbal medicines; Small molecules
- Mechanism of Action Angiogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Endometriosis
Most Recent Events
- 28 Apr 2023 Preclinical development is ongoing for Endometriosis in Hong Kong
- 28 Apr 2023 Adverse events and pharmacodynamics data from preclinical studies in Endometriosis released by Aptorum group
- 28 Jan 2023 No recent reports of development identified for preclinical development in Endometriosis in Hong Kong (PO)